Patient Resources
- Home
- Patient Resources
- Search Results
Get Healthy!
Results for search "Multiple Sclerosis".
09 Apr
Experimental Drug Shows Promise in Slowing Disability from Multiple Sclerosis
Results of a phase 3 clinical trial show an experimental drug called tolebrutinib can delay disability in patients with non-relapsing secondary progressive multiple sclerosis.
Health News Results - 85
Menopause does not increase symptoms and disability among women with multiple sclerosis, a major new study has concluded.
Some experts had been concerned that fluctuating hormone levels associated with menopause might affect severity of the neurodegenerative disease...
- Dennis Thompson HealthDay Reporter
- |
- October 3, 2025
- |
- Full Page
The early warning signs of multiple sclerosis appear to be the same for everyone, regardless of their background.
The pain, mood changes, brain decline and neurological problems associated with early MS can appear years before diagnosis, but appear to affect all types of people in similar ways, according to a new study.
“Our study shows that the very earliest features of MS ar...
- Dennis Thompson HealthDay Reporter
- |
- October 1, 2025
- |
- Full Page
Ultra-processed foods could be making matters worse for people in the early throes of multiple sclerosis (MS), a new study says.
Higher consumption of ultra-processed eats is linked to more frequent relapses in early MS patients, researchers reported Thursday at the annual meeting of the European Committee for Treatment and Research in Multiple Sclerosis in Barcelona.
Brain scans al...
- Dennis Thompson HealthDay Reporter
- |
- September 26, 2025
- |
- Full Page
Nearly 4 out of 5 American neurologists prescribing multiple sclerosis (MS) drugs have received at least one payment from the pharmaceutical industry, a new study reports.
Those who prescribe larger amounts of MS drugs were more likely to have received payments, and those who got payments were more likely to prescribe the company’s drugs, especially if the payments were larger, sust...
- Dennis Thompson HealthDay Reporter
- |
- September 18, 2025
- |
- Full Page
Multiple sclerosis (MS) patients might have a higher risk of relapse if their health insurance is stingy with prescriptions, a new study reports.
Patients with insurance plans that exclude coverage of some MS treatments have a significantly higher risk of developing new or worsening symptoms, researchers reported Aug. 1 in
People with multiple sclerosis (MS) begin experiencing new health issues up to 15 years before the classic signs of the illness appear, Canadian research shows.
“MS can be difficult to recognize as many of the earliest signs — like fatigue, headache, pain and mental health concerns — can be quite general and easily mistaken for other conditions,” study senior autho...
- HealthDay Reporter
- Ernie Mundell
- |
- August 4, 2025
- |
- Full Page
Women are less likely than men to receive multiple sclerosis (MS) meds that could help them manage the disease and delay disability, a new report finds.
It could be that some women in their childbearing years are hesitant to use certain drugs in and around pregnancy, but the researchers noted that gender gaps in treatment persisted even for drugs that have proven to be safe during p...
- HealthDay Reporter
- Ernie Mundell
- |
- July 31, 2025
- |
- Full Page
People living with an autoimmune disease are nearly twice as likely to suffer from mood problems like depression, anxiety or bipolar disorder, a new large-scale study says.
The risk of mood disorders is 87% to 97% higher in people suffering from rheumatoid arthritis, inflammatory bowel disease, lupus, multiple ...
- HealthDay Reporter
- Dennis Thompson
- |
- June 25, 2025
- |
- Full Page
A blood test might predict when multiple sclerosis patients are about to suffer a relapse in their symptoms, a new study says.
Blood levels of a protein called neurofilament light chain rise significantly in MS patients up to a year before they have a relapse, researchers reported Monday at a meeting of the European Academy of Neurology in Helsinki.
This sort of early detection can ...
- HealthDay Reporter
- Dennis Thompson
- |
- June 24, 2025
- |
- Full Page
Kids with multiple sclerosis (MS) age at an accelerated rate as the disease causes advanced wear and tear on their bodies, a new study says.
This accelerated aging extends into their teenage years, increasing their odds that MS-related disability and chronic disease will occur earlier in their lives, researchers reported June 9 in the journal
Artificial intelligence (AI) can help detect when a person’s multiple sclerosis (MS) has reached an advanced state, a new study says.
A newly developed AI correctly judged with 90% accuracy when a person’s MS had transitioned to a stage where it will progress steadily, researchers reported recently in the journal
An experimental drug can help patients with advanced multiple sclerosis (MS) delay the progressive disability that comes with their disorder, a new clinical trial suggests.
The drug, tolebrutinib, delayed disability progression by 31% in people with a type of MS called non-relapsing secondary progressive multiple sclerosis (SPM...
- HealthDay Reporter
- Dennis Thompson
- |
- April 9, 2025
- |
- Full Page
A diet rich in fish might slow the progression of multiple sclerosis in some patients, a new study says.
The nutrients found in fish can quell inflammation and protect brain cells, and this might be of particular benefit for MS patients, researchers reported in the Journal of Neurology Neurosurgery & Psychiatry...
- HealthDay Reporter
- Dennis Thompson
- |
- February 26, 2025
- |
- Full Page
Children who develop multiple sclerosis appear to fare better if they were exposed to safe amounts of summer sunshine as infants, new research shows.
If their moms got some summer sun while pregnant, that seemed to help, too, according to a study published Feb. 12 in the journal
People with multiple sclerosis (MS) have been concerned that a COVID-19 infection could cause the symptoms of their nerve disease to become even worse.
But a new study should offer some solace -- COVID doesn’t appear to worsen MS, researchers reported Dec. 23, 2024 in the journal
For children genetically predisposed to develop multiple sclerosis (MS), exposure to cigarette smoke in the family home could raise that risk even higher, new research shows.
"A higher genetic MS risk is associated with an increased vulnerability to the negative effects of household smoking on brain development," conclude a Dutch team led by
A child from a poorer neighborhood is more prone to severe illness once they develop multiple sclerosis (MS) compared to children growing up in more affluent areas, new research shows.
The study of 138 MS patients who'd been diagnosed before the age of 18 revealed that kids from less advantaged neighborhoods showed larger volumes of inflammation and brain tissue loss, compared to those fr...
- HealthDay Reporter
- Ernie Mundell
- |
- November 29, 2024
- |
- Full Page
A person battling multiple sclerosis spent an average of $750 in out-of-pocket fees on medicines in 2012, but by 2021 that same patient spent $2,378 annually, a new report finds.
Out-of-pocket costs for drugs for neurologic diseases such as MS, Parkinson's and
Medication and behavioral therapy are both effective in combatting fatigue caused by multiple sclerosis (MS), either separately or together, a new study finds.
MS patients felt significantly less fatigue after they were prescribed modafinil (Provigil), a drug that promotes wakefulness and is used to treat sleepiness, researchers repor...
- HealthDay Reporter
- Dennis Thompson
- |
- October 25, 2024
- |
- Full Page
There's a small but significant increased of certain cancers in people battling multiple sclerosis (MS), new research shows.
Those malignancies include cancers of the bladder, brain and cervix, said a team from Rennes University in France.
“People with MS undergo an increased number of tests to monitor MS, making it more likely to detect other diseases,” said study autho...
- HealthDay Reporter
- Ernie Mundell
- |
- October 10, 2024
- |
- Full Page
Two key symptoms that can arise soon after a diagnosis of multiple sclerosis (MS) could predict how swiftly the illness will progress and suggest best treatment options, new research shows.
The two symptoms -- blurred vision and sphincter dysfunction of the bladder and/or bowel -- can arise in some, but not all, patients early in the disease.
When they do surface so quickly, patient...
- HealthDay Reporter
- Ernie Mundell
- |
- September 25, 2024
- |
- Full Page
Early, aggressive treatment of brain lesions caused by multiple sclerosis could help ward off faster decline in patients, a new study finds.
Such treatment could prevent or potentially cure paramagnetic rim lesions (PRL), areas of chronic brain inflammation that are linked to more rapid deterioration in MS patients, researchers report.
“Checking PRL levels is not currently a s...
- HealthDay Reporter
- Dennis Thompson
- |
- September 18, 2024
- |
- Full Page
People with multiple sclerosis appear to have a lower risk of developing Alzheimer’s disease, a new study suggests.
MS patients are far less likely to have elevated blood levels of toxic proteins that form amyloid plaques in the brains of people with Alzhe...
- HealthDay Reporter
- Dennis Thompson
- |
- August 27, 2024
- |
- Full Page
Multiple sclerosis makes people vulnerable to more severe cases of COVID-19, but a new study finds that getting the COVID vaccine won't trigger a relapse of MS symptoms.
“People with MS have an increased risk of severe COVID infection due to their level of motor disability or exposure to treatments that suppress their immune systems,” explained study lead author
A new monoclonal antibody treatment called Kesimpta (ofatumumab) appears to improve on an older drug in pushing multiple sclerosis (MS) into remission, a new trial shows.
Funded by Kesimpta's maker, Novartis, the trial compared the new therapy against teriflunomide (Aubagio), an immune-...
- HealthDay Reporter
- Ernie Mundell
- |
- July 18, 2024
- |
- Full Page
The discovery that the Epstein-Barr virus might be a major driver of multiple sclerosis has re-energized research into the autoimmune disease.
Now, investigators in the U.K. and Sweden believe they might be closer to understanding how the virus, which also causes mononucleosis, might help spur MS.
"The discovery of the link between Epstein-Barr Virus [EBV] and multiple sclerosis ha...
- HealthDay Reporter
- Ernie Mundell
- |
- June 19, 2024
- |
- Full Page
Climate change is likely to make brain conditions like stroke, migraine, Alzheimer's disease, epilepsy and multiple sclerosis even worse, a new review warns.
The potential effects of a changing climate is likely to be substantial on a range of neurological conditions, researche...
- HealthDay Reporter
- Dennis Thompson
- |
- May 16, 2024
- |
- Full Page
Advanced scanning techniques can find hidden inflammation in the brains of multiple sclerosis (MS) patients, a new study shows.
This "smoldering"inflammation detected by positron emission tomography (PET) brain scans could help explain why patients continue to decline even though imaging shows no brain changes, researchers reported recently in the journal
An early marker of multiple sclerosis could help doctors figure out who will eventually fall prey to the degenerative nerve disease, a new study says.
In one in 10 cases of MS, the body begins producing a distinctive set of antibodies in the blood years before symptoms start appearing, researchers reported April 19 in the journal
Children who are obese face double the odds of developing multiple sclerosis later in life, a new study warns.
The overall odds for any one child to develop the neurodegenerative illness remains very low. However, the Swedish researchers believe the link could help explain rising rates of MS.
"There are several studies showing that MS has increased over several decades and obesity ...
- HealthDay Reporter
- Ernie Mundell
- |
- March 29, 2024
- |
- Full Page
Chemicals found in common household products might damage the brain's wiring, a new study warns.
These chemicals -- found in disinfectants, cleaners, hair products, furniture and textiles -- could be linked to degenerative brain diseases like multiple sclerosis and autism, researchers report.
The chemicals specifically affect the brain's oligodendrocytes, a specialized type of cell ...
Actress Christina Applegate, who has been battling multiple sclerosis (MS) since 2021, shared her struggles with the debilitating disease on Monday.
"I live kind of in hell. I'm not out a lot, so this is a little difficult, just for my system. But of course, the support is wonderful, and I'm really grateful,"Applegate noted in an interview on
Certain drugs used to treat multiple sclerosis appear to be safe for babies if taken by breastfeeding moms, a new study finds.
Breastfed babies whose moms received monoclonal antibody treatments for MS did not develop any more developmental delays than babies not exposed to the drugs through breast milk. The findings will be presented at the American Academy of Neurology's upcoming annual...
- HealthDay Reporter
- Dennis Thompson
- |
- March 5, 2024
- |
- Full Page
Young Black and Hispanic women diagnosed with multiple sclerosis are more likely to fare worse than young white women do, a new study shows.
Specifically, they are more likely to have advanced MS and to face greater challenges during pregnancy, according to findings published Jan. 23 in the journal Neurology.
"We found that Black and Hispanic women faced socioeconomic disad...
- HealthDay Reporter
- |
- January 24, 2024
- |
- Full Page
DNA locked in the bones and teeth of more than 5,000 humans who lived in Asia and Europe up to 34,000 years ago are providing vital clues to a myriad of present-day medical conditions.
The descendants of these ancient peoples are living now in Europe and throughout the world. But their forebearers' genetic legacy lingers, according to researchers who presented their findings in four studi...
- HealthDay Reporter
- Ernie Mundell
- |
- January 11, 2024
- |
- Full Page
Pain can present itself in many forms for people battling multiple sclerosis, and one type can interfere with exercising, new research shows.
One class of pain experienced by MS patients is what the authors of the new study call nociceptive, caused by specific damage to tissues. Another form is neuropathic pain, caused by the loss of the protective myelin sheath around nerves that is a ha...
- HealthDay Reporter
- Ernie Mundell
- |
- January 11, 2024
- |
- Full Page
There's information emerging on how the common Epstein-Barr virus (EBV) might be crucial to triggering multiple sclerosis (MS).
The virus, which also causes "mono" (mononucleosis) and other illnesses, has gained prominence in recent years as a potential cause of MS. Over 95% of people are thought to carry EBV, although for most people it remains dormant.
Now, a team of Texan researc...
- HealthDay Reporter
- Ernie Mundell
- |
- January 8, 2024
- |
- Full Page
Patients in the earliest stages of multiple sclerosis might develop certain symptoms that offer an early clue to the degenerative nerve disease, researchers report.
Depression, constipation, urinary tract infections and sexual problems are all more likely in MS patients five years before their official diagnosis, compared with people who never develop MS, researchers found.
Those co...
- HealthDay Reporter
- Dennis Thompson
- |
- December 6, 2023
- |
- Full Page
Stem cells injected into the brains of multiple sclerosis patients appear to protect them against further damage from the degenerative disease, a new study shows.
MS occurs when the body's own immune system attacks and damages the protective sheath around nerve fibers, called myelin. This disrupts messages sent around the brain and spinal cord.
MS patients who received a fetal stem ...
- HealthDay Reporter
- Dennis Thompson
- |
- November 28, 2023
- |
- Full Page
Researchers have found a remedy for the debilitating fatigue faced by many patients with multiple sclerosis (MS): A low-fat diet.
"The results reinforced what we had seen before," said study leader Dr. Vijayshree Yadav, director of the Multiple Sclerosis Center at Oregon Health & Science University in Portl...
- HealthDay Reporter
- |
- November 14, 2023
- |
- Full Page
A new study is strengthening the evidence that stem cell transplants can be highly effective for some people with multiple sclerosis -- sending the disease into remission for years, and sometimes reversing disability.
Researchers found that of 174 MS patients who underwent stem cell transplants -- with cells from their own blood -- two-thirds had no evidence of "disease activity" over 10 ...
- HealthDay Reporter
- Amy Norton
- |
- September 27, 2023
- |
- Full Page
A newer understanding of multiple sclerosis (MS) suggests that psychiatric conditions like anxiety and depression may emerge long before classic MS symptoms.
"For a long time, it was thought that MS only really began clinically when a person experienced their first demyelinating event, such as in the form of vision problems,"said senior author
A large number of drugs used to treat everything from multiple sclerosis to blood cancers to rheumatoid arthritis may cause a rare but often-fatal condition called progressive multifocal leukoencephalopathy (PML).
But a simple genetic test can determine who has a 10-fold higher risk for developing this condition, which means those patients could discuss safer treatment options with their ...
- HealthDay Reporter
- Cara Murez
- |
- September 13, 2023
- |
- Full Page
Patients with a type of multiple sclerosis (MS) known as relapsing-remitting MS could have less fatigue if they got more active and were in better physical shape, according to new research.
The study also found that a lower disability rate was also associated with less fatigue.
"The fi...
- HealthDay Reporter
- Cara Murez
- |
- August 9, 2023
- |
- Full Page
Patients who get treatment for multiple sclerosis at the earliest signs of disease may have a lower risk of disability later, new research suggests.
Among nearly 600 patients, there were lower odds of disability and progression among people diagnosed and treated within six months of symptoms onset, researchers report in their new study, published recently in the journal
For the first time, scientists have identified a genetic variant that may make some people with multiple sclerosis (MS) vulnerable to faster progression.
In a study of more than 22,000 people with MS, researchers found that those who carried a particular genetic variant faced a faster decline: They needed to use a walking aid about four years earlier, on average, than people who did not c...
- HealthDay Reporter
- Amy Norton
- |
- June 29, 2023
- |
- Full Page
Women with multiple sclerosis temporarily get much better when pregnant, and researchers now think they know why.
Pregnancy causes a downshift in a woman's immune system, and it appears that this unintentionally improves symptoms associated with the autoimmune disorder MS, according to a new study published recently in the
For years, multiple sclerosis was seen as a disease that largely affects white people. But a new study finds that it's much more common among Black Americans than previously believed.
Researchers found that in 2010, an estimated 3 out of every 1,000 Black Americans were living with multiple sclerosis (MS). That was less than the prevalence among white Americans, at 4 out of every 1,000, b...
- HealthDay Reporter
- Amy Norton
- |
- June 14, 2023
- |
- Full Page
Multiple sclerosis (MS) is a chronic disease that attacks the central nervous system and leaves patients suffering from a host of symptoms, and now new research finds life stressors can make those symptoms even worse.
Poverty, abuse and divorce in childhood and adulthood can significantly impact the level of disability someone with MS experiences, according to researchers from Michigan Me...
- HealthDay Reporter
- Cara Murez
- |
- May 29, 2023
- |
- Full Page
It's been known for years that Epstein-Barr virus can trigger multiple sclerosis or drive progression of the degenerative disease, and Swedish researchers think they now understand why.
Some people have antibodies against the common Epstein-Barr virus that mistakenly attack a protein found in the brain and spinal cord, researchers at the Karolinska Institute in Sweden say.
Antibodie...
- HealthDay Reporter
- Dennis Thompson
- |
- May 18, 2023
- |
- Full Page
Our commitment to patient care and health is priority one here at Save N Care Pharmacy.
We believe in the value of providing personalized service and quality products.
Site Navigation
Contact Us
13850 Little Road, Hudson, FL 34667
(727) 863-5200 - (727) 863-5225
2025 © All Rights Reserved. Privacy Policy SMS Terms